Immunogen reported $38.08M in Sales Revenues for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Sales Change
Abbvie ABBV:US $ 13538M 1348M
Amgen AMGN:US $ 6238M 608M
Astellas Pharma 4503:JP Y 303870M 36757M
AstraZeneca AZN:LN 11390M 621M
Bluebird Bio BLUE:US $ 1.94M 0.34M
Bristol Myers Squibb BMY:US $ 11648M 337M
Eli Lilly And LLY:US $ 7810M 189.9M
Emergent Biosolutions EBS:US $ 307.5M 415.7M
Exelixis EXEL:US $ 355.98M 95.16M
Halozyme Therapeutics HALO:US $ 117.28M 15.28M
Heron Therapeutics HRTX:US $ 23.46M 2.8M
Immunogen IMGN:US $ 38.08M 10.09M
Intrexon XON:US $ 32.02M 7.8M
Karyopharm Therapeutics KPTI:US $ 47.67M 78.6M
Macrogenics MGNX:US $ 11.1M 3.05M
Nektar Therapeutics NKTR:US $ 24.82M 0.19M
Novartis NVS:US $ 12814M 708M
Pfizer PFE:US $ 25661M 2026M
Regeneron Pharmaceuticals REGN:US $ 2965.1M 1986.6M
Roche Holding ROG:VX 16.44B 474M
Seattle Genetics SGEN:US $ 426.46M 3.39M